Abstract
The likelihood of amyloid deposition in the cerebral vasculature (cerebral amyloid angiopathy; CAA) increases with age1-3. Particularly in Alzheimer’s disease (AD), CAA can be detected in up to 90% of the patients4-6. CAA of the ß-amyloid-type (Aß-CAA) affects primarily leptomeningeal and cortical vessels and is associated with degeneration of smooth muscle cells and endothelial cells, as well as blood-brain barrier damage. Severe Aß-CAA can cause fatal cerebral hemorrhage and increases the risk of cerebral microinfarcts7-9. Genetic variations that are causative or risk factors for Aß-CAA have been identified, such as mutations in the genes for ß-amyloid precursor protein (APP), presenilins 1 and 2, and possibly cystatin C, as well as polymorphisms in apolipoprotein E3. In normal aging and AD, Aß-CAA is associated with parenchymal Aß plaques. However, Aß-CAA can also occur in the absence of plaques, as evidenced in hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D)10-12.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Tomonaga M (1981) Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 29: 151–157.
Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14: 924–928.
Walker LC, Durham RA (1999) Cerebrovascular amyloidosis: experimental analysis in vitro and in vivo. Histol Histopathol 14: 827–837.
Esiri MM, Wilcock GK (1986) Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 49: 1221–1226.
Yamada M, Tsukagoshi H, Otomo E et al. (1987) Cerebral amyloid angiopathy in the aged. J Neurol 234: 371–376.
Yamada M (2000) Cerebral amyloid angiopathy: an overview. Neuropathology 20: 822.
Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18: 311–324.
Itoh Y, Yamada M, Hayakawa M et al. (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116: 135–141.
Vonsattel JP, Myers RH, Hedley-Whyte ET et al. (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30: 637–649.
Wattendorff AR, Bots GT, Went LN et al. (1982) Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J Neurol Sci 55: 121–135.
Haan J, Hardy JA, Roos RA (1991) Hereditary cerebral hemorrhage with amyloidosis-Dutch type: its importance for Alzheimer research. Trends Neurosci 14: 231–234.
Levy E, Carman MD, Fernandez-Madrid et al. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124–1126.
Walker LC (1997) Animal models of cerebral beta-amyloid angiopathy. Brain Res Rev 25: 70–84.
Wisniewski HM, Frackowiak J, Mazur-Kolecka B (1995) In vitro production of betaamyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 183: 120–123.
Wei LH, Walker LC, Levy E (1996) Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. Stroke 27: 2080–2085.
Games D, Adams D, Alessandrini R, et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523–527.
Hsiao K, Chapman P, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99–102.
Holtzman DM, Fagan AM, Mackey B et al. (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model. Ann Neurol 47: 739–747.
Sturchler-Pierrat C, Abramowski D, Duke M et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287–13292.
Calhoun ME, Burgermeister P, Phinney AL et al. (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96: 14088–14093.
Winkler DT, Bondolfi L, Herzig MC et al. (2000) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. (submitted)
Van Dorpe J, Smeijers L, Dewachter I et al. (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol (in press)
Mandybur TI (1975) The incidence of cerebral amyloid angiopathy in Alzheimer’s disease. Neurology 25: 120–126.
Ellis RJ, Olichney JM, Thal LJ et al. (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46: 1592–1596.
Wyss-Coray T, Masliah E, Mallory M et al. (1997) Amyloidogenic role of cytokine TGF-betal in transgenic mice and in Alzheimer’s disease. Nature 389: 603–606.
Hendriks L, van Duijn CM, Cras P et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1: 218–221.
Cras P, van Harskamp F, Hendriks L et al. (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->GIy mutation. Acta Neuropathol 96: 253–260.
Kumar-Singh S, Ceuterick C, Lubke U et al. (2000) Pathology of Flemish APP692 Alzheimer’s disease suggests that core containing plaques are angiocentric. Neurobiol Aging 21: S66.
Kumar-Singh S, Dewachter I, Moechars D et al. (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7: 9–22.
Levy E, Lopez-Otin C, Ghiso J et al. (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169: 1771–1778.
Vidal R, Frangione B, Rostagno A et al. (1999) A stop-codon mutation in theBRIgene associated with familial British dementia. Nature 399: 776–781.
Vidal R, Revesz T, Rostagno A et al. (2000) A decamer duplication in the 3’ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97: 4920–4925.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herzig, M.C., Winkler, D.T., Walker, L.C., Jucker, M. (2001). Transgenic Mouse Models of Cerebral Amyloid Angiopathy. In: Tolnay, M., Probst, A. (eds) Neuropathology and Genetics of Dementia. Advances in Experimental Medicine and Biology, vol 487. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1249-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1249-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5461-1
Online ISBN: 978-1-4615-1249-3
eBook Packages: Springer Book Archive